Get Your Personalized Supplement StackSupplement Stack Quiz

Female Hops Cone Extract

Also known as: Female hops cone extract, Hop extract, Humulus lupulus

Overview

Female hops cone extract is derived from the flowers (cones) of the hop plant, *Humulus lupulus*. Traditionally used in brewing and medicine, it is primarily utilized to alleviate menopausal symptoms, particularly vasomotor symptoms like hot flashes, due to its phytoestrogenic properties. The extract contains prenylated flavonoids, with 8-prenylnaringenin (8-PN) identified as a potent phytoestrogen that binds to estrogen receptors. Research on hops extract for menopausal symptom relief is moderately mature, with several randomized controlled trials (RCTs) and at least one systematic review/meta-analysis supporting its efficacy. While evidence quality is moderate, with generally well-conducted trials, limitations often include sample size and duration. More large-scale, long-term RCTs are recommended to further solidify the evidence base. It is categorized as a botanical dietary supplement and a phytoestrogenic herbal extract.

Benefits

The primary benefit of female hops cone extract is a significant reduction in the frequency and severity of menopausal hot flashes and other vasomotor symptoms. Meta-analyses have shown a statistically significant decrease in hot flash frequency by approximately 20–25% over 8–12 weeks compared to placebo controls. This effect is considered moderately clinically significant, comparable to low-dose hormone replacement therapy but with a more favorable safety profile. Secondary effects may include mild improvements in sleep quality and mood, though the evidence for these is less robust. The benefits appear most relevant for peri- and early postmenopausal women experiencing vasomotor symptoms. Symptom relief typically begins within 4 weeks of supplementation and may continue to improve over 12 weeks.

How it works

The primary mechanism of action for female hops cone extract involves its phytoestrogenic activity, mainly through 8-prenylnaringenin (8-PN). 8-PN binds to estrogen receptors, specifically ERα and ERβ, stimulating estrogen-responsive gene expression. This includes effects such as alkaline phosphatase activity and progesterone receptor mRNA upregulation in estrogen-sensitive cells. By modulating peripheral estrogen receptor pathways involved in thermoregulation, the extract helps alleviate hot flashes. While other bioactive compounds may contribute through antioxidant and anti-inflammatory effects, these mechanisms are less characterized. The absorption of prenylated flavonoids is moderate, and bioavailability can vary depending on the formulation.

Side effects

Female hops cone extract is generally considered safe and well-tolerated in clinical trials lasting up to 12 weeks. Common side effects are rare, but may include mild gastrointestinal discomfort or headache. Uncommon side effects (1-5%) can include allergic reactions or mild hormonal effects. No serious adverse events or significant drug interactions have been consistently reported. However, due to its phytoestrogenic activity, it is contraindicated in individuals with hormone-sensitive cancers, and caution is advised for women with a history of breast, uterine, or ovarian cancer. Safety during pregnancy and lactation has not been established, and its use is not recommended in these populations. Long-term safety data beyond 12 weeks are currently limited.

Dosage

Effective doses of standardized hop extract in clinical trials typically range from 100 mg to 250 mg daily. It is crucial that the extract is standardized to contain a defined amount of 8-prenylnaringenin (e.g., 0.5–1.0 mg of 8-PN) to ensure consistent efficacy. A duration of at least 4–12 weeks of consistent use is generally necessary to observe the full benefits. The supplement is commonly administered orally in capsule or tablet form. Taking the extract with meals may enhance absorption. While no specific cofactors are required, consistent daily dosing is recommended for optimal results. There are no specific upper limits or safety thresholds established beyond the typical clinical trial dosages, but adherence to recommended amounts is advised.

FAQs

Is female hops cone extract a natural alternative to hormone replacement therapy (HRT)?

Yes, it offers a phytoestrogenic alternative with fewer side effects compared to conventional HRT, though it is generally less potent in its effects.

How quickly can I expect results?

Symptom improvement typically begins within 4 weeks of consistent use, with maximal effects usually observed around 8–12 weeks of supplementation.

Is it safe for long-term use?

Long-term safety data for female hops cone extract are not well established. Short-term use, up to 12 weeks, appears to be safe and well-tolerated.

Can it be used with other supplements or medications?

No significant interactions have been consistently reported. However, caution is advised, especially with hormone-sensitive conditions or medications that affect hormone levels.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC5016504/ – This review article summarizes clinical trials on hops extract, highlighting its estrogenic activity and significant reduction in menopausal hot flashes. It concludes that prenylated flavonoids from hops are promising alternatives to HRT but calls for larger randomized controlled trials to confirm findings.
https://pubs.acs.org/doi/10.1021/acs.chemrestox.8b00345 – This systematic review and meta-analysis of hop compounds, including clinical trials, found statistically significant reductions in hot flash frequency (approximately 20–25%) at weeks 4, 8, and 12 compared to placebo. It confirmed 8-prenylnaringenin as a potent phytoestrogen mediating these effects.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12388921/ – This systematic review focuses on the broader biological effects of hop-derived compounds, including their anticancer potential. While not specifically on menopausal symptoms, it supports the general bioactivity and safety profile of hop extracts, reinforcing their pharmacological relevance and potential.